Recombinant factor VIIa for life-threatening post-partum haemorrhage (multiple letters) [1]

British Journal of Anaesthesia

Volumn 95, Issue 4, 2005, Pages 558-

  Butwick, A J ^a   Riley, E T ^a   Ahonen, Jouni ^a   Jokela, R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UTEROTONIC AGENT;

ACIDOSIS; ANEMIA; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; CRYOPRECIPITATION; DISEASE SEVERITY; DRUG COST; DRUG DOSE REGIMEN; ERYTHROCYTE TRANSFUSION; FATALITY; HEMOSTASIS; HUMAN; HYPOTHERMIA; HYSTERECTOMY; LETTER; OBSTETRIC HEMORRHAGE; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

EID: 26444609692     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aei594     Document Type: Letter

References (4)

1. J Ahonen R Jokela Recombinant factor VIIa for life-threatening post-partum haemorrhage Br J Anaesth 94 2005 592 595
2. DR Spahn MA Tucci M Makris Editorial: Is recombinant FVIIa the magic bullet in the treatment of major bleeding? Br J Anaesth 94 2005 553 555
3. U Martinowitz G Kenet E Segal Recombinant activated factor VII for adjunctive hemorrhage control in trauma J Trauma 51 2001 431 439
4. A Veldman M Hoffman S Ehrenforth A new insight into the coagulation system and implications for new therapeutic options with recombinant factor VIIa Curr Med Chem 10 2003 797 811